A phase Ib study of pertuzumab (P), a recombinant humanized antibody to HER2, and docetaxel (D) in patients (pts) with advanced solid tumors
Gerhardt Attard(London Cancer), Maja J. De Jonge(Roche (Switzerland)), Gerhard Zugmaier(Amgen (Germany)), Jianguo Zhi(Roche (Switzerland)), Sarah P. Blagden(Churchill Hospital), Johann S. de Bono(Royal Marsden NHS Foundation Trust), Jos Kitzen(Erasmus MC), Jaap Verweij(Deutz (Germany)), L. Pronk(Roche (Switzerland)), Sarah Reade(Roche (Switzerland))
Cited by 8
Related Papers
Integrative Clinical Genomics of Advanced Prostate Cancer
|Cell|2015|3.6k
Enzalutamide in Metastatic Prostate Cancer before Chemotherapy
|New England Journal of Medicine|2014|3k
Abiraterone in Metastatic Prostate Cancer without Previous Chemotherapy
|New England Journal of Medicine|2012|2.8k
DNA-Repair Defects and Olaparib in Metastatic Prostate Cancer
|New England Journal of Medicine|2015|2.2k
Cremophor EL
|European Journal of Cancer|2001|1.6k